By: Dr. Sukaina Alzyoud & Dr. Ahmad "Jordan" Alz'ubi
Jordan Daily - Living longer is one of society's greatest achievements. But added years do not automatically become healthy years. When people live longer with diabetes, cardiovascular disease, obesity, depression, frailty, or several conditions at once, longevity stops being only a demographic fact. Preventable illness becomes a financial exposure borne by families, employers, insurers, hospitals, and public budgets.
This is the health side of longevity risk. In pensions, longer-than-expected lives can extend benefit payments and place pressure on institutions such as Jordan's Social Security Corporation. That important actuarial question deserves a separate discussion. The concern here is different: whether added years will be healthy and independent, or increasingly marked by illness, disability, and costly treatment.
Longer Lives Change the Balance Sheet
Jordan already faces a heavy burden of non-communicable disease, while its population will age substantially in the coming decades. The future cost of ageing is therefore being formed long before people reach old age, through blood pressure, glucose, weight, tobacco exposure, physical inactivity, mental health, and conditions that remain undiagnosed or poorly controlled.
Health economists distinguish among three possible futures. In an expansion of morbidity, people live longer but spend more years in poor health. Under dynamic equilibrium, illness may last longer but become less severe. The best outcome is compression of morbidity: serious illness and loss of function are postponed toward the end of life. Age alone is not the whole cost story. Research shows that patterns of illness and proximity to death often explain healthcare expenditure better than birthdays do.
The balance sheet also extends beyond hospitals. Chronic disease reduces productivity, increases absenteeism and caregiving demands, narrows household income, and creates repeated out-of-pocket spending. Poor health weakens the very economic benefit that longevity can create: experienced people remaining active, independent, socially connected, and able to contribute.
Prevention Has an Incentive Problem
Jordan's health system, like many systems, is better organized to treat episodes of illness than to sustain prevention between visits. Yet prevention is often underprovided not because its value is unknown, but because its benefits arrive later and may accrue to someone other than the payer. An employer, insurer, or household may bear the cost today while another insurer, a future government budget, or society captures the saving years later.
Health insurance creates additional incentives. Coverage protects families from ruinous bills, but when payment begins mainly after illness, patients, providers, and insurers may all have too little reason to invest in prevention. Short insurance relationships can intensify the problem: why finance a long-term intervention if the beneficiary may soon move elsewhere? The solution is not less insurance. It is insurance designed to reward earlier action, continuity, and measurable health outcomes.
A nationwide cohort study in Taiwan found that a combination of healthy behaviors was associated with longer life expectancy and lower annual healthcare expenditure. The estimates cannot simply be transferred to Jordan, and association is not proof that every program will work. Prevention can improve health without immediately saving money. The correct test is whether an intervention creates sufficient health and function for its cost.
From Recording Illness to Preventing It
Jordan has already invested in digitizing care through Hakeem and related services. The next question is whether this infrastructure will merely record illness or help prevent and delay it. A collection of disconnected apps, appointment portals, generic tips, and unvalidated artificial-intelligence features is not a prevention system. Digitizing a fragmented care pathway merely produces digital fragmentation.
A sound service begins with a longitudinal view of the person. With consent and appropriate safeguards, it should connect screening results, laboratory data, medications, symptoms, lifestyle patterns, and clinical follow-up. It should help people understand risk, set realistic goals, monitor progress, and know when self-management is no longer enough. It must support plain Arabic and recognize how family roles, food practices, stigma, income, geography, gender, and digital access shape whether advice can be followed.
Services should be organized around verified prevention pathways rather than screen time. Cardiometabolic support, for example, can combine risk assessment with nutrition, physical activity, sleep, tobacco cessation, medication adherence, and timely referral. The digital layer should extend care, not pretend to be care. Clinicians remain responsible for clinical judgment; technology can make their work more continuous, personalized, and reachable.
Trust and Equity Are Part of the Treatment
Prevention platforms influence how people behave and interpret symptoms. That influence creates responsibility. Governance must address clinical evidence, privacy, cybersecurity, bias, explainability, accountability, and safety throughout the product life cycle. A walking reminder is not equivalent to an algorithm interpreting laboratory results or suggesting changes to hormone therapy. Higher-risk functions require stronger validation, professional oversight, human review, and monitoring.
Digital health can also narrow or widen inequality. Older adults, rural communities, refugees, people with disabilities, and lower-income households may face barriers involving devices, connectivity, literacy, language, cost, or trust. Low-bandwidth access, accessible design, caregiver options, community and primary-care entry points, and non-smartphone alternatives are therefore essential. Success should be judged by equitable health outcomes, not downloads or engagement alone.
A Layered Insurance Architecture
Universal health protection can support this agenda if it is designed carefully. Jordan could move toward a guaranteed basic package for all, complemented by regulated commercial insurance for additional benefits. China offers a useful, though not perfect, comparison: basic medical insurance covers about 95 percent of its population, while commercial coverage plays a supplementary role. Jordan should not copy another system, but it can learn from the principle of a broad public floor with room for complementary private protection.
Such a model would require coordination among the Ministry of Health, Social Security Corporation, Central Bank, insurers, providers, and digital-health institutions. Risk adjustment and common standards would be needed so insurers compete through service and prevention rather than by attracting only healthier people. The financing architecture deserves fuller treatment elsewhere, but healthspan should be built into it from the beginning.
What Jordan Should Build
Jordan does not need one giant application. It needs governed digital prevention infrastructure within which trustworthy public, private, academic, and community services can operate. The priorities are clear: national quality and risk-classification standards; interoperable data linking primary care, laboratories, pharmacies, insurers, and electronic records; payment for verified prevention pathways; carefully supervised regulatory sandboxes; and prevention and digital-health literacy for the public and workforce.
Outcome-based payment must also guard against easy victories. Platforms and providers should not be rewarded for selecting healthier participants or avoiding difficult cases. Evaluation requires risk adjustment, meaningful comparison, sufficient follow-up, independent auditing, and measures of clinical improvement, function, equity, and cost-effectiveness.
Healthspan Is National Wealth
The central question is not simply how Jordan will finance more years of life. It is how many of those years people will spend healthy, independent, productive, and connected to their communities. Every dinar has an alternative use. Money directed toward avoidable late complications cannot simultaneously support early screening, behavior change, mental health, rehabilitation, or community prevention.
The answer is not to ration necessary treatment or promise that every preventive measure will save money. It is to reduce avoidable illness, delay serious complications, and learn continuously from outcomes. Living longer is good news. Building a culture and a system that help people live those additional years in better health is the real return on investment.
